FLS
63
2
PSX
25
-12
HPQ
37
2
V
54
2
THC
48
2
OI
58
11
FITB
78
3
PCG
77
3
DLTR
58
-5
INTC
40
-3
ZTS
25
4
URI
49
3
CHRW
79
-3
HRL
35
12
BMY
78
2
PNR
54
3
LMT
62
3
TRIP
52
3
NTAP
56
-3
TGT
50
-7
FLS
63
2
PSX
25
-12
HPQ
37
2
V
54
2
THC
48
2
OI
58
11
FITB
78
3
PCG
77
3
DLTR
58
-5
INTC
40
-3
ZTS
25
4
URI
49
3
CHRW
79
-3
HRL
35
12
BMY
78
2
PNR
54
3
LMT
62
3
TRIP
52
3
NTAP
56
-3
TGT
50
-7
Financhill
Back

Nuveen Credit Strategies Income Fund Vs. Oruka Therapeutics, Inc. Industry Stock Comparison

Buy
62

JQC
Nuveen Credit Strategies Income Fund

Last Price:
$5.01
Seasonality Move:
0.94%
Sell
40

ORKA
Oruka Therapeutics, Inc.

Last Price:
$32.34
Seasonality Move:
-10.99%
Buy
62
Nuveen Credit Strategies Income Fund (JQC) is a Buy

Is Nuveen Credit Strategies Income Fund a Buy, Sell or Hold?

  • The current Nuveen Credit Strategies Income Fund [JQC] share price is $4.99. The Score for JQC is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
  • JQC is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
40
Oruka Therapeutics, Inc. (ORKA) is a Sell

Is Oruka Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Oruka Therapeutics, Inc. [ORKA] share price is $31.97. The Score for ORKA is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • ORKA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

JQC Stock Price Chart

What is Nuveen Credit Strategies Income Fund's stock price today?

  • The Nuveen Credit Strategies Income Fund share price today is $4.99
    The current trend is relatively stagnant and JQC is experiencing selling pressure, which indicates risk of future bearish movement.

ORKA Stock Price Chart

What is Oruka Therapeutics, Inc.'s stock price today?

  • The Oruka Therapeutics, Inc. share price today is $31.97
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ORKA is experiencing slight buying pressure.

JQC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 40.52 Sell
Chaikin Money Flow: -1277009 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (4.98 - 5.08) Sell
Bollinger Bands (100): (5.04 - 5.44) Sell

ORKA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.74 Buy
Relative Strength Index (14 RSI): 61.53 Buy
Chaikin Money Flow: 394649 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (28.23 - 31.09) Buy
Bollinger Bands (100): (15.89 - 28.91) Buy

JQC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 5.01 Sell
20-day SMA: 5.05 Sell
50-day SMA: 5.06 Sell
200-day SMA: 5.28 Sell
8-day EMA: 5.01 Sell
20-day EMA: 5.03 Sell
50-day EMA: 5.09 Sell
200-day EMA: 5.28 Sell

ORKA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 29.97 Buy
20-day SMA: 30.06 Buy
50-day SMA: 28.52 Buy
200-day SMA: 16.89 Buy
8-day EMA: 30.34 Buy
20-day EMA: 29.78 Buy
50-day EMA: 27.54 Buy
200-day EMA: 21.05 Buy

Nuveen Credit Strategies Income Fund Earnings Growth & JQC Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Oruka Therapeutics, Inc. Earnings Growth & ORKA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.63 per share, and a decrease next year of $0.32 per share.

Nuveen Credit Strategies Income Fund Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Oruka Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):